Ryan Kellogg
Cofounder/CEO @ RTHM (YC W22 🍊) and investor | PhD, Transforming Healthcare
2025Venture Partner· Pioneer Fund
Founder · since 2022Company
Pioneer Fund
Role
Venture Partner
current
Stage
—
no public source
Raised
—
no public source
Based
—
Founder / co-founder — the company's markEmployee / research role
Source: LinkedIn work historyProfile coverage5 of 7 · missing posts, contact
Experience
Career
2022RTHM
Co-founderCofounder/CEO · 2022 – Present
2025Pioneer Fund
Venture Partner · 2025 – Present
2016Stanford University School of Medicine
Research Scientist, Snyder Lab · 2016 – 2021
Bio
Dr. Kellogg’s struggle with a mystery illness led him to pioneer technology for measuring thousands of molecules in self-collected blood microsamples. This allows for a better understanding of health fluctuations and the impacts of health interventions in detail. When combined with wearable sensors and symptom tracking, this technology allows for real-time health monitoring and pattern discovery with unprecedented resolution. PhD in Microfluidics and Systems Biology from ETH Zurich.